The global tumor ablation market size is anticipated to reach USD 4.0 billion by 2030, according to the report. It is anticipated to expand at a CAGR of 13.5% from 2024 to 2030. An increasing incidence of cancer and high demand for effective treatment options are the major factors contributing to market growth. According to the International Agency for Research on Cancer, 19,292,789 cancer cases were reported in 2020, and are expected to reach 50,550,287 by 2025. Breast, lung, colorectum, prostate, and stomach are the most common cancers reported. The growing preference for minimally invasive procedures, attributed to advantages like fast recovery, patient comfort, and shorter turnaround times, is projected to drive demand for advanced tumor ablation techniques. ![Global Tumor Ablation Market]( "Global Tumor Ablation Market")
Furthermore, the integration of such devices with highly effective interventional imaging technologies, such as ultrasound, MRI, and CT, is poised to bring about a transformation in ablation procedures conducted in outpatient settings. This shift is anticipated to substantially reduce costs for patients, including expenses related to hospital stays. Government-sponsored initiatives, including screening programs, awareness campaigns, and specific cancer schemes, are projected to increase the number of diagnosed cases. For instance, in 2019, the National Health Scheme (NHS) in England initiated lung cancer screening programs in selected regions. Such initiatives are expected to increase the demand for early-stage cancer management, thus driving market growth.
Furthermore, the integration of such devices with highly effective interventional imaging technologies, such as ultrasound, MRI, and CT, is poised to bring about a transformation in ablation procedures conducted in outpatient settings. This shift is anticipated to substantially reduce costs for patients, including expenses related to hospital stays. Government-sponsored initiatives, including screening programs, awareness campaigns, and specific cancer schemes, are projected to increase the number of diagnosed cases. For instance, in 2019, the National Health Scheme (NHS) in England initiated lung cancer screening programs in selected regions. Such initiatives are expected to increase the demand for early-stage cancer management, thus driving market growth.
Tumor Ablation Market Report Highlights
- Radiofrequency ablation technology segment led the market with a share of more than 32.7% in 2023 owing to prominent application in solid tumor removal
- Microwave ablation segment is expected to grow at the fastest CAGR of 14.27% from 2024 to 2030
- The percutaneous ablation treatment segment held the largest revenue share of about 56.7% in 2023
- Tumor ablation in lung cancer treatment is anticipated to witness the fastest growth from 2024 to 2030. Sedentary lifestyle, increasing incidences of smoking, and rising air pollution are contributing to the growing prevalence of lung cancer
- North America led the global market in 2023 owing to increased prevalence of cancer, high purchasing power parity, government support for quality healthcare, and availability of reimbursement
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Technology
1.1.2. Treatment
1.1.3. Application
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.1.1. Technology
1.1.2. Treatment
1.1.3. Application
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Treatment outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Treatment outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Tumor Ablation Market: Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising incidence of cancer
3.2.1.2. Technological advancements in ablation devices
3.2.1.3. Increasing per capita income
3.2.1.4. Growing demand of minimally invasive surgeries.
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations & approvals
3.2.2.2. Presence of alternative treatment options
3.3. Tumor Ablation Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising incidence of cancer
3.2.1.2. Technological advancements in ablation devices
3.2.1.3. Increasing per capita income
3.2.1.4. Growing demand of minimally invasive surgeries.
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations & approvals
3.2.2.2. Presence of alternative treatment options
3.3. Tumor Ablation Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Tumor Ablation Market: Technology Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Radiofrequency ablation
4.1.2. Microwave ablation
4.1.3. Cryoablation
4.1.4. Irreversible electroporation ablation
4.1.5. HIFU
4.1.6. Other ablation technologies
4.2. Technology Market Share, 2023 & 2030
4.3. Segment Dashboard
4.4. Global Tumor Ablation Market by Technology Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Radiofrequency ablation
4.5.1.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.5.2. Microwave Ablation
4.5.2.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.5.3. Cryoablation
4.5.3.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.5.4. Irreversible electroporation ablation
4.5.4.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.5.5. HIFU
4.5.5.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.5.6. Other ablation technologies
4.5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.1.1. Radiofrequency ablation
4.1.2. Microwave ablation
4.1.3. Cryoablation
4.1.4. Irreversible electroporation ablation
4.1.5. HIFU
4.1.6. Other ablation technologies
4.2. Technology Market Share, 2023 & 2030
4.3. Segment Dashboard
4.4. Global Tumor Ablation Market by Technology Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Radiofrequency ablation
4.5.1.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.5.2. Microwave Ablation
4.5.2.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.5.3. Cryoablation
4.5.3.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.5.4. Irreversible electroporation ablation
4.5.4.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.5.5. HIFU
4.5.5.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.5.6. Other ablation technologies
4.5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Tumor Ablation Market: Treatment Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Surgical ablation
5.1.2. Laparoscopic ablation
5.1.3. Percutaneous ablation
5.2. Treatment Market Share, 2023 & 2030
5.3. Segment Dashboard
5.4. Global Tumor Ablation Market by Treatment Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Surgical Ablation
5.5.1.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
5.5.2. Laparoscopic Ablation
5.5.2.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
5.5.3. Percutaneous Ablation
5.5.3.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
5.1.1. Surgical ablation
5.1.2. Laparoscopic ablation
5.1.3. Percutaneous ablation
5.2. Treatment Market Share, 2023 & 2030
5.3. Segment Dashboard
5.4. Global Tumor Ablation Market by Treatment Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Surgical Ablation
5.5.1.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
5.5.2. Laparoscopic Ablation
5.5.2.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
5.5.3. Percutaneous Ablation
5.5.3.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
Chapter 6. Tumor Ablation Market: Application Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Kidney cancer
6.1.2. Liver cancer
6.1.3. Breast cancer
6.1.4. Lung cancer
6.1.5. Prostate cancer
6.1.6. Other cancer
6.2. Application Market Share, 2023 & 2030
6.3. Segment Dashboard
6.4. Global Tumor Ablation Market by Application Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Kidney cancer
6.5.1.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
6.5.2. Liver cancer
6.5.2.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
6.5.3. Breast cancer
6.5.3.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
6.5.4. Lung cancer
6.5.4.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
6.5.5. Prostate cancer
6.5.5.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
6.5.6. Other cancer
6.5.6.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
6.1.1. Kidney cancer
6.1.2. Liver cancer
6.1.3. Breast cancer
6.1.4. Lung cancer
6.1.5. Prostate cancer
6.1.6. Other cancer
6.2. Application Market Share, 2023 & 2030
6.3. Segment Dashboard
6.4. Global Tumor Ablation Market by Application Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Kidney cancer
6.5.1.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
6.5.2. Liver cancer
6.5.2.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
6.5.3. Breast cancer
6.5.3.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
6.5.4. Lung cancer
6.5.4.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
6.5.5. Prostate cancer
6.5.5.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
6.5.6. Other cancer
6.5.6.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
Chapter 7. Tumor Ablation Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. U.S. Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Canada Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. UK Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Germany Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6.3. France
7.6.3.1. France Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Italy Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Spain Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Norway Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Sweden Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Denmark Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Japan Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.7.2. China
7.7.2.1. China Market Size Sstimates and Forecast, 2018 - 2030 (USD Million)
7.7.3. India
7.7.3.1. India Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Australia Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. South Korea Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Thailand Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Brazil Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.8.2. Mexico
7.8.2.1. Mexico Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Argentina Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. South Africa Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Saudi Arabia Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.9.3. UAE
7.9.3.1. UAE Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Kuwait Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. U.S. Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Canada Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. UK Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Germany Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6.3. France
7.6.3.1. France Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Italy Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Spain Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Norway Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Sweden Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Denmark Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Japan Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.7.2. China
7.7.2.1. China Market Size Sstimates and Forecast, 2018 - 2030 (USD Million)
7.7.3. India
7.7.3.1. India Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Australia Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. South Korea Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Thailand Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Brazil Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.8.2. Mexico
7.8.2.1. Mexico Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Argentina Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. South Africa Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Saudi Arabia Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.9.3. UAE
7.9.3.1. UAE Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Kuwait Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
Chapter 8. Competitive Analysis
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Medtronic
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Boston Scientific Corporation
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Johnson & Johnson Service Inc. (Ethicon, Inc.)
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. AngioDynamics
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Bioventus Inc. (Misonix Inc.)
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. EDAP TMS
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Chongqing Haifu Medical Technology Co., Ltd
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Mermaid Medical
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. HealthTronics, Inc.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. H.S. Hospital Service S.p.A.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Medtronic
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Boston Scientific Corporation
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Johnson & Johnson Service Inc. (Ethicon, Inc.)
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. AngioDynamics
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Bioventus Inc. (Misonix Inc.)
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. EDAP TMS
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Chongqing Haifu Medical Technology Co., Ltd
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Mermaid Medical
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. HealthTronics, Inc.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. H.S. Hospital Service S.p.A.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America tumor ablation market, by region, 2018 - 2030 (USD Million)
Table 3 North America tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 4 North America tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 5 North America tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 6 North America tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 7 U.S. tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 8 U.S. tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 9 U.S. tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 10 Canada tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 11 Canada tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 12 Canada tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 13 Europe tumor ablation market, by region, 2018 - 2030 (USD Million)
Table 14 Europe tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 15 Europe tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 16 Europe tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 17 Germany tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 18 Germany tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 19 Germany tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 20 UK tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 21 UK tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 22 UK tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 23 France tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 24 France tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 25 France tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 26 Italy tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 27Italy tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 28 Italy tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 29 Spain tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 30 Spain tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 31 Spain tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 32 Denmark tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 33 Denmark tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 34 Denmark tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 35 Sweden tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 36 Sweden tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 37 Sweden tumor ablation market, by application,2018 - 2030 (USD Million)
Table 39 Norway tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 40 Norway tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 41 Norway tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 42 Asia Pacific tumor ablation market, by region, 2018 - 2030 (USD Million)
Table 43 Asia Pacific tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 44 Asia Pacific tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 45 Asia Pacific tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 46 China tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 47 China tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 48 China tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 49Japan tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 50 Japan tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 51 Japan tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 52 India tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 53 India tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 54 India tumor ablation market, by application2018 - 2030 (USD Million)
Table 55 South Korea tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 56 South Korea tumor ablation market, by treatment,2018 - 2030 (USD Million)
Table 57 South Korea tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 58 Australia tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 59 Australia tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 60 Australia tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 61 Thailand tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 62 Thailand tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 63 Thailand tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 64 Latin America tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 65 Latin America tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 66 Latin America surgical ablation market, by application, 2018 - 2030 (USD Million)
Table 67 Latin America laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
Table 68 Latin America percutaneous ablation market, by application, 2018 - 2030 (USD Million)
Table 69Latin America tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 70 Brazil tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 71 Brazil tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 72 Brazil surgical ablation market, by application, 2018 - 2030 (USD Million)
Table 73 Brazil laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
Table 74 Brazil percutaneous ablation market, by application, 2018 - 2030 (USD Million)
Table 75 Brazil tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 76 Mexico tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 77 Mexico tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 78 Mexico surgical ablation market, by application, 2018 - 2030 (USD Million)
Table 79 Mexico laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
Table 80 Mexico percutaneous ablation market, by application, 2018 - 2030 (USD Million)
Table 81 Mexico tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 82 Argentina tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 83 Argentina tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 84 Argentina surgical ablation market, by application, 2018 - 2030 (USD Million)
Table 85 Argentina laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
Table 86 Argentina percutaneous ablation market, by application, 2018 - 2030 (USD Million)
Table 87 Argentina tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 88 MEA tumor ablation market, by region, 2018 - 2030 (USD Million)
Table 89 MEA tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 90 MEA tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 91 MEA tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 92 South Africa tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 93 South Africa tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 94 South Africa tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 95 Saudi Arabia tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 96 Saudi Arabia tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 97 Saudi Arabia tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 98 UAE tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 99 UAE tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 100 UAE tumor ablation market, by application,2018 - 2030 (USD Million)
Table 101 Kuwait tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 102 Kuwait tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 103 Kuwait tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 2 North America tumor ablation market, by region, 2018 - 2030 (USD Million)
Table 3 North America tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 4 North America tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 5 North America tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 6 North America tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 7 U.S. tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 8 U.S. tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 9 U.S. tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 10 Canada tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 11 Canada tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 12 Canada tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 13 Europe tumor ablation market, by region, 2018 - 2030 (USD Million)
Table 14 Europe tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 15 Europe tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 16 Europe tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 17 Germany tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 18 Germany tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 19 Germany tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 20 UK tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 21 UK tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 22 UK tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 23 France tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 24 France tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 25 France tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 26 Italy tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 27Italy tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 28 Italy tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 29 Spain tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 30 Spain tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 31 Spain tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 32 Denmark tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 33 Denmark tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 34 Denmark tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 35 Sweden tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 36 Sweden tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 37 Sweden tumor ablation market, by application,2018 - 2030 (USD Million)
Table 39 Norway tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 40 Norway tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 41 Norway tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 42 Asia Pacific tumor ablation market, by region, 2018 - 2030 (USD Million)
Table 43 Asia Pacific tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 44 Asia Pacific tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 45 Asia Pacific tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 46 China tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 47 China tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 48 China tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 49Japan tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 50 Japan tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 51 Japan tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 52 India tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 53 India tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 54 India tumor ablation market, by application2018 - 2030 (USD Million)
Table 55 South Korea tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 56 South Korea tumor ablation market, by treatment,2018 - 2030 (USD Million)
Table 57 South Korea tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 58 Australia tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 59 Australia tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 60 Australia tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 61 Thailand tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 62 Thailand tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 63 Thailand tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 64 Latin America tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 65 Latin America tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 66 Latin America surgical ablation market, by application, 2018 - 2030 (USD Million)
Table 67 Latin America laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
Table 68 Latin America percutaneous ablation market, by application, 2018 - 2030 (USD Million)
Table 69Latin America tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 70 Brazil tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 71 Brazil tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 72 Brazil surgical ablation market, by application, 2018 - 2030 (USD Million)
Table 73 Brazil laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
Table 74 Brazil percutaneous ablation market, by application, 2018 - 2030 (USD Million)
Table 75 Brazil tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 76 Mexico tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 77 Mexico tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 78 Mexico surgical ablation market, by application, 2018 - 2030 (USD Million)
Table 79 Mexico laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
Table 80 Mexico percutaneous ablation market, by application, 2018 - 2030 (USD Million)
Table 81 Mexico tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 82 Argentina tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 83 Argentina tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 84 Argentina surgical ablation market, by application, 2018 - 2030 (USD Million)
Table 85 Argentina laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
Table 86 Argentina percutaneous ablation market, by application, 2018 - 2030 (USD Million)
Table 87 Argentina tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 88 MEA tumor ablation market, by region, 2018 - 2030 (USD Million)
Table 89 MEA tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 90 MEA tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 91 MEA tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 92 South Africa tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 93 South Africa tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 94 South Africa tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 95 Saudi Arabia tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 96 Saudi Arabia tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 97 Saudi Arabia tumor ablation market, by application, 2018 - 2030 (USD Million)
Table 98 UAE tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 99 UAE tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 100 UAE tumor ablation market, by application,2018 - 2030 (USD Million)
Table 101 Kuwait tumor ablation market, by technology, 2018 - 2030 (USD Million)
Table 102 Kuwait tumor ablation market, by treatment, 2018 - 2030 (USD Million)
Table 103 Kuwait tumor ablation market, by application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Tumor ablation market: market outlook
Fig. 14 Tumor ablation competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Tumor ablation market driver impact
Fig. 20 Tumor ablation market restraint impact
Fig. 21 Tumor ablation market strategic initiatives analysis
Fig. 22 Tumor ablation market: Technology movement analysis
Fig. 23 Tumor ablation market: Technology outlook and key takeaways
Fig. 24 Radiofrequency ablation market estimates and forecast, 2018 - 2030
Fig. 25 Microwave ablation estimates and forecast, 2018 - 2030
Fig. 26 Cryoablation market estimates and forecast, 2018 - 2030
Fig. 27 Irreversible electroporation ablation estimates and forecast, 2018 - 2030
Fig. 28 HIFU market estimates and forecast, 2018 - 2030
Fig. 29 Others estimates and forecast, 2018 - 2030
Fig. 30 Tumor ablation Market: Treatment Movement Analysis
Fig. 31 Tumor ablation market: Treatment outlook and key takeaways
Fig. 32 Surgical ablation market estimates and forecast, 2018 - 2030
Fig. 33 Percutaneous ablation market estimates and forecast,2018 - 2030
Fig. 34 Laparoscopic ablation market estimates and forecast,2018 - 2030
Fig. 35 Tumor ablation market: application movement analysis
Fig. 36 Tumor ablation market: application outlook and key takeaways
Fig. 37 Kidney cancer market estimates and forecast, 2018 - 2030
Fig. 38 Liver cancer market estimates and forecast,2018 - 2030
Fig. 39 Breast cancer market estimates and forecast, 2018 - 2030
Fig. 40 Lung cancer market estimates and forecast,2018 - 2030
Fig. 41 Prostate cancer market estimates and forecast, 2018 - 2030
Fig. 42 Other market estimates and forecast,2018 - 2030
Fig. 43 Global tumor ablation market: Regional movement analysis
Fig. 44 Global tumor ablation market: Regional outlook and key takeaways
Fig. 45 Global tumor ablation market share and leading players
Fig. 46 North America market share and leading players
Fig. 47 Europe market share and leading players
Fig. 48 Asia Pacific market share and leading players
Fig. 49 Latin America market share and leading players
Fig. 50 Middle East & Africa market share and leading players
Fig. 51 North America: SWOT
Fig. 52 Europe SWOT
Fig. 53 Asia Pacific SWOT
Fig. 54 Latin America SWOT
Fig. 55 MEA SWOT
Fig. 56 North America, by country
Fig. 57 North America
Fig. 58 North America market estimates and forecast, 2018 - 2030
Fig. 59 U.S.
Fig. 60 U.S. market estimates and forecast, 2018 - 2030
Fig. 61 Canada
Fig. 62 Canada market estimates and forecast, 2018 - 2030
Fig. 63 Europe
Fig. 64 Europe market estimates and forecast, 2018 - 2030
Fig. 65 UK
Fig. 66 UK market estimates and forecast, 2018 - 2030
Fig. 67 Germany
Fig. 68 Germany market estimates and forecast, 2018 - 2030
Fig. 69 France
Fig. 70 France market estimates and forecast, 2018 - 2030
Fig. 71 Italy
Fig. 72 Italy market estimates and forecast, 2018 - 2030
Fig. 73 Spain
Fig. 74 Spain market estimates and forecast, 2018 - 2030
Fig. 75 Denmark
Fig. 76 Denmark market estimates and forecast, 2018 - 2030
Fig. 77 Sweden
Fig. 78 Sweden market estimates and forecast, 2018 - 2030
Fig. 79 Norway
Fig. 80 Norway market estimates and forecast, 2018 - 2030
Fig. 81 Asia Pacific
Fig. 82 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 83 China
Fig. 84 China market estimates and forecast, 2018 - 2030
Fig. 85 Japan
Fig. 86 Japan market estimates and forecast, 2018 - 2030
Fig. 87 India
Fig. 88 India market estimates and forecast, 2018 - 2030
Fig. 89 Thailand
Fig. 90 Thailand market estimates and forecast, 2018 - 2030
Fig. 91 South Korea
Fig. 92 South Korea market estimates and forecast, 2018 - 2030
Fig. 93 Australia
Fig. 94 Australia market estimates and forecast, 2018 - 2030
Fig. 95 Latin America
Fig. 96 Latin America market estimates and forecast, 2018 - 2030
Fig. 97 Brazil
Fig. 98 Brazil market estimates and forecast, 2018 - 2030
Fig. 99 Mexico
Fig. 100 Mexico market estimates and forecast, 2018 - 2030
Fig. 101 Argentina
Fig. 102 Argentina market estimates and forecast, 2018 - 2030
Fig. 103 Middle East and Africa
Fig. 104 Middle East and Africa market estimates and forecast, 2018 - 2030
Fig. 105 South Africa
Fig. 106 South Africa market estimates and forecast, 2018 - 2030
Fig. 107 Saudi Arabia
Fig. 108 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 109 UAE
Fig. 110 UAE market estimates and forecast, 2018 - 2030
Fig. 111 Kuwait
Fig. 112 Kuwait market estimates and forecast, 2018 - 2030
Fig. 113 Market share of key market players - Tumor ablation market
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Tumor ablation market: market outlook
Fig. 14 Tumor ablation competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Tumor ablation market driver impact
Fig. 20 Tumor ablation market restraint impact
Fig. 21 Tumor ablation market strategic initiatives analysis
Fig. 22 Tumor ablation market: Technology movement analysis
Fig. 23 Tumor ablation market: Technology outlook and key takeaways
Fig. 24 Radiofrequency ablation market estimates and forecast, 2018 - 2030
Fig. 25 Microwave ablation estimates and forecast, 2018 - 2030
Fig. 26 Cryoablation market estimates and forecast, 2018 - 2030
Fig. 27 Irreversible electroporation ablation estimates and forecast, 2018 - 2030
Fig. 28 HIFU market estimates and forecast, 2018 - 2030
Fig. 29 Others estimates and forecast, 2018 - 2030
Fig. 30 Tumor ablation Market: Treatment Movement Analysis
Fig. 31 Tumor ablation market: Treatment outlook and key takeaways
Fig. 32 Surgical ablation market estimates and forecast, 2018 - 2030
Fig. 33 Percutaneous ablation market estimates and forecast,2018 - 2030
Fig. 34 Laparoscopic ablation market estimates and forecast,2018 - 2030
Fig. 35 Tumor ablation market: application movement analysis
Fig. 36 Tumor ablation market: application outlook and key takeaways
Fig. 37 Kidney cancer market estimates and forecast, 2018 - 2030
Fig. 38 Liver cancer market estimates and forecast,2018 - 2030
Fig. 39 Breast cancer market estimates and forecast, 2018 - 2030
Fig. 40 Lung cancer market estimates and forecast,2018 - 2030
Fig. 41 Prostate cancer market estimates and forecast, 2018 - 2030
Fig. 42 Other market estimates and forecast,2018 - 2030
Fig. 43 Global tumor ablation market: Regional movement analysis
Fig. 44 Global tumor ablation market: Regional outlook and key takeaways
Fig. 45 Global tumor ablation market share and leading players
Fig. 46 North America market share and leading players
Fig. 47 Europe market share and leading players
Fig. 48 Asia Pacific market share and leading players
Fig. 49 Latin America market share and leading players
Fig. 50 Middle East & Africa market share and leading players
Fig. 51 North America: SWOT
Fig. 52 Europe SWOT
Fig. 53 Asia Pacific SWOT
Fig. 54 Latin America SWOT
Fig. 55 MEA SWOT
Fig. 56 North America, by country
Fig. 57 North America
Fig. 58 North America market estimates and forecast, 2018 - 2030
Fig. 59 U.S.
Fig. 60 U.S. market estimates and forecast, 2018 - 2030
Fig. 61 Canada
Fig. 62 Canada market estimates and forecast, 2018 - 2030
Fig. 63 Europe
Fig. 64 Europe market estimates and forecast, 2018 - 2030
Fig. 65 UK
Fig. 66 UK market estimates and forecast, 2018 - 2030
Fig. 67 Germany
Fig. 68 Germany market estimates and forecast, 2018 - 2030
Fig. 69 France
Fig. 70 France market estimates and forecast, 2018 - 2030
Fig. 71 Italy
Fig. 72 Italy market estimates and forecast, 2018 - 2030
Fig. 73 Spain
Fig. 74 Spain market estimates and forecast, 2018 - 2030
Fig. 75 Denmark
Fig. 76 Denmark market estimates and forecast, 2018 - 2030
Fig. 77 Sweden
Fig. 78 Sweden market estimates and forecast, 2018 - 2030
Fig. 79 Norway
Fig. 80 Norway market estimates and forecast, 2018 - 2030
Fig. 81 Asia Pacific
Fig. 82 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 83 China
Fig. 84 China market estimates and forecast, 2018 - 2030
Fig. 85 Japan
Fig. 86 Japan market estimates and forecast, 2018 - 2030
Fig. 87 India
Fig. 88 India market estimates and forecast, 2018 - 2030
Fig. 89 Thailand
Fig. 90 Thailand market estimates and forecast, 2018 - 2030
Fig. 91 South Korea
Fig. 92 South Korea market estimates and forecast, 2018 - 2030
Fig. 93 Australia
Fig. 94 Australia market estimates and forecast, 2018 - 2030
Fig. 95 Latin America
Fig. 96 Latin America market estimates and forecast, 2018 - 2030
Fig. 97 Brazil
Fig. 98 Brazil market estimates and forecast, 2018 - 2030
Fig. 99 Mexico
Fig. 100 Mexico market estimates and forecast, 2018 - 2030
Fig. 101 Argentina
Fig. 102 Argentina market estimates and forecast, 2018 - 2030
Fig. 103 Middle East and Africa
Fig. 104 Middle East and Africa market estimates and forecast, 2018 - 2030
Fig. 105 South Africa
Fig. 106 South Africa market estimates and forecast, 2018 - 2030
Fig. 107 Saudi Arabia
Fig. 108 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 109 UAE
Fig. 110 UAE market estimates and forecast, 2018 - 2030
Fig. 111 Kuwait
Fig. 112 Kuwait market estimates and forecast, 2018 - 2030
Fig. 113 Market share of key market players - Tumor ablation market
Companies Profiled
- Medtronic
- Boston Scientific Corporation
- Johnson & Johnson Service Inc. (Ethicon, Inc.)
- AngioDynamics
- Bioventus Inc. (Misonix Inc.)
- EDAP TMS
- Chongqing Haifu Medical Technology Co., Ltd
- Mermaid Medical
- HealthTronics, Inc.
- H.S. Hospital Service S.p.A.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | November 2023 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 1.67 Billion |
| Forecasted Market Value ( USD | $ 4 Billion |
| Compound Annual Growth Rate | 13.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
